Skip to menu Skip to content Skip to footer

2007

Journal Article

Comparison of the outcomes between open and minimally invasive esophagectomy

Smithers, Bernard M., Gotley, David C., Martin, Ian and Thomas, Janine M. (2007). Comparison of the outcomes between open and minimally invasive esophagectomy. Annals of Surgery, 245 (2), 232-240. doi: 10.1097/01.sla.0000225093.58071.c6

Comparison of the outcomes between open and minimally invasive esophagectomy

2007

Journal Article

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

Gebski, V., Burmeister, B., Smithers, B. M., Foo, K., Zalcberg, J. and Simes, J. (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncology, 8 (3), 226-234. doi: 10.1016/S1470-2045(07)70039-6

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

2007

Journal Article

Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy

Smithers, B. M., Cullinan, M., Thomas, J. M., Martin, I., Barbour, A. P., Burmeister, B. H., Harvey, J. A., Thomson, D. B., Walpole, E. T. and Gotley, D. C. (2007). Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy. Diseases of The Esophagus, 20 (6), 471-477. doi: 10.1111/j.1442-2050.2007.00701.x

Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy

2006

Journal Article

Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002

Coory, Michael, Baade, Peter, Aitken, Joanne, Smithers, Mark, McLeod, G. Roderick C. and Ring, Ian (2006). Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes & Control, 17 (1), 21-27. doi: 10.1007/s10552-005-3637-4

Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002

2006

Journal Article

Minimally invasive esophagectomy

Leibman, S., Smithers, B. M., Gotley, D. C., Martin, I. and Thomas, J. (2006). Minimally invasive esophagectomy. Surgical Endoscopy And Other Interventional Techniques, 20 (3), 428-433. doi: 10.1007/s00464-005-0388-y

Minimally invasive esophagectomy

2006

Journal Article

Radiotherapy for metastatic melanoma presenting in pregnancy

Daly, T., Burmeister, B, Smithers, B M, Doody, J. and Kane, A. (2006). Radiotherapy for metastatic melanoma presenting in pregnancy. Australasian Radiology, 50 (6), 598-603. doi: 10.1111/j.1440-1673.2006.01641.x

Radiotherapy for metastatic melanoma presenting in pregnancy

2006

Journal Article

Urban-rural differences in survival from cutaneous melanoma in Queensland

Coory, Michael, Smithers, Mark, Aitken, Joanne, Baade, Peter and Ring, Ian (2006). Urban-rural differences in survival from cutaneous melanoma in Queensland. Australian & New Zealand Journal of Public Health, 30 (1), 71-74. doi: 10.1111/j.1467-842X.2006.tb00089.x

Urban-rural differences in survival from cutaneous melanoma in Queensland

2006

Journal Article

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma - Trans Tasman Radiation Oncology Group (TROG) Study 96.06

Burmeister, Bryan H., Smithers, B. Mark, Burmeister, Elizabeth, Baumann, Kathryn, Davis, Sidney, Krawitz, Hedley, Johnson, Carol and Spry, Nigel (2006). A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma - Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiotherapy and Oncology, 81 (2), 136-142. doi: 10.1016/j.radonc.2006.10.001

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma - Trans Tasman Radiation Oncology Group (TROG) Study 96.06

2005

Journal Article

Acute and long-term effect of alpha-glucosidase inhibitor on dumping syndrome in a patient after a vagotomy and pyloric surgery *

Smith, Louise, Smithers, Mark, Prins, Johannes and O'Moore-Sullivan, Trisha (2005). Acute and long-term effect of alpha-glucosidase inhibitor on dumping syndrome in a patient after a vagotomy and pyloric surgery *. The Australian and New Zealand Journal of Surgery, 75 (12), 1124-1126. doi: 10.1111/j.1445-2197.2005.03628.x

Acute and long-term effect of alpha-glucosidase inhibitor on dumping syndrome in a patient after a vagotomy and pyloric surgery *

2005

Journal Article

Neoadjuvant chemoadiotherapy in resectable oesophageal cancer - Authors' reply

Burmeister, Bryan H. and Smithers, B.Mark (2005). Neoadjuvant chemoadiotherapy in resectable oesophageal cancer - Authors' reply. Lancet Oncology, 6 (11), 825-826. doi: 10.1016/S1470-2045(05)70402-2

Neoadjuvant chemoadiotherapy in resectable oesophageal cancer - Authors' reply

2005

Journal Article

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus

Smith, Kylie J., O'Brien, Suzanne M., Smithers, B. Mark, Gotley, David C., Webb, Penelope M., Green, Adèle C. and Whiteman, David C. (2005). Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiology Biomarkers & Prevention, 14 (11), 2481-2486. doi: 10.1158/1055-9965.EPI-05-0370

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus

2005

Journal Article

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors’ reply

Burmeister, Bryan H. and Smithers, B. Mark (2005). Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors’ reply. Lancet Oncology, 6 (11), 825-825. doi: 10.1016/S1470-2045(05)70402-2

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors’ reply

2005

Journal Article

Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery

Byrne, J. P., Smithers, B. M., Nathanson, L. K., Martin, I., Ong, H. S. and Gotley, D. C. (2005). Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery. British Journal of Surgery, 92 (8), 996-1001. doi: 10.1002/bjs.4914

Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery

2005

Journal Article

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

Burmeister, B. H., Smithers, B. M., Gebski, V., Fitzgerald, L., Simes, R. J., Devitt, P., Ackland, S., Gotley, D. C., Joseph, D., Millar, J., North, J., Walpole, E. T. and Denham, J. W. (2005). Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncology, 6 (9), 659-668. doi: 10.1016/S1470-2045(05)70288-6

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

2005

Journal Article

Novel approach to oesophageal resection

Smithers, Mark (2005). Novel approach to oesophageal resection. ANZ Journal of Surgery, 75 (12), 1029-1029. doi: 10.1111/j.1445-2197.2005.03661.x

Novel approach to oesophageal resection

2005

Journal Article

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer

Pramesh, C. S., Mistry, Rajesh C., Laskar, Sarbani G., Burmeister, Bryan H. and Smithers, B. Mark (2005). Neoadjuvant chemoradiotherapy in resectable oesophageal cancer. Lancet Oncology, 6 (11), 824-825. doi: 10.1016/S1470-2045(05)70401-0

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer

2005

Journal Article

Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin

Burmeister, B., Walpole, E. T., Burmeister, E., Thomas, J., Thomson, D. B., Harvey, J., Smithers, B. M. and Gotley, D. C. (2005). Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin. International Journal of Clinical Oncology, 10 (4), 256-261. doi: 10.1007/s10147-005-0506-9

Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin

2004

Journal Article

Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia

Harvey, J. A., Bessell, J. R., Beller, E., Thomas, J., Gotley, D. C., Burmeister, B. H., Walpole, E. T., Thomson, D. B., Martin, I., Doyle, L., Burmeister, E. and Smithers, B. M. (2004). Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia. Diseases of The Esophagus, 17 (3), 260-265. doi: 10.1111/j.1442-2050.2004.00420.x

Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia

2004

Journal Article

Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy

Brown, WA, Thomas, J, Gotley, D, Burmeister, BH, Lim, KH, Martin, I, Walpole, ET, Thomson, DB, Harvey, JA and Smithers, BM (2004). Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy. British Journal of Surgery, 91 (2), 199-204. doi: 10.1002/bjs.4411

Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy

2003

Journal Article

High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients

Stowasser, Michael, Gordon, Richard D., Gunasekera, Thanuja G., Cowley, Diane C., Ward, Gregory, Archibald, Colin and Smithers, B. Mark (2003). High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. Journal of Hypertension, 21 (11), 2149-2157. doi: 10.1097/01.hjh.0000098141.70956.53

High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients